RxAll

Research says that counterfeit medication is the cause of 1 million deaths per year. One-tenth of this number comes from Africa. Counterfeiting is hard to detect, investigate, quantify or stop. It is a global problem, with annual earnings from substandard drugs standing at over $100 billion.

Some technologies have helped deal with this menace; for instance, radio frequency identification, which works by assigning serial numbers to containers of each product. More modern approaches are being adopted these days, which is the case of RxAll, a startup using deep technology to provide quality medication to patients. Today, the U.S. and Nigerian-based company is announcing a financing round of $3.15 million to scale across existing markets and improve its technology.

RxAll was founded in 2016 by Adebayo Alonge, Amy Kao and Wei Lui. As students at Yale University, the trio came together to collectively solve a problem they faced firsthand, either personally or relating to a loved one.

In 2006, Alonge was a victim of fake pharmaceuticals and almost died after taking medicine that contained lethal levels of diazepam. He went into a coma for three weeks.

“I survived a 21-day coma in Nigeria 15 years ago. My co-founder, Amy, was hospitalized …read more

Source:: TechCrunch – Startups

      

(Visited 2 times, 1 visits today)

NASA Chooses Spacex To Launch A Self Propelled Space Station To The Moon

Leave a Reply

Your email address will not be published. Required fields are marked *